Abstract
In this paper, we selected Pt(en)Cl4, Pt(dach)Cl4, and Pt(bipy)Cl4 with gradually increasing ligands to explore the ligand effect on the properties of platinum(IV) anticancer drugs. The electronic structures and multiple drug properties of these three complexes were studied at the LSDA/SDD level using the density functional theory (DFT) method. By comparing the gap between the highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital (LUMO), electron affinity, atomic charge population, and natural bond orbital (NBO), we found that the order of reducibility is Pt(bipy)Cl4 > Pt(en)Cl4 > Pt(dach)Cl4. Our research can provide the theoretical basis for the development of anticancer drugs.
Reference47 articles.
1. Theoretical Study on Electronic Structures and Medical Properties of Pt Complexes as Antitumor Drug;Guang;Chin Clin Pharmacol Ther,2000
2. ChemInform Abstract: Current Status of Platinum-Based Antitumor Drugs;Wong;onAcademic,1999
3. Platinum(IV) Anticancer Complexes;Hall;Metal Ions Biolog Syst,2004
4. Cisplatin in Cancer Therapy: Molecular Mechanisms of Action;Dasari;Eur J Pharmacol,2014
5. Polymeric Biomaterials for the Delivery of Platinum-Based Anticancer Drugs;Kim;Biomat Sci,2015
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献